{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:29:50Z","timestamp":1794356990737,"version":"4.9.0"},"reference-count":64,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"\n Importance<\/jats:title>\n Risk estimation is an integral part of cardiovascular care. Local recalibration of guideline-recommended models could address the limitations of existing tools.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To provide a machine learning (ML) approach to augment the performance of the American Heart Association\u2019s Predicting Risk of Cardiovascular Disease Events (AHA-PREVENT) equations when applied to a local population while preserving clinical interpretability.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used a New England\u2013based electronic health record cohort of patients without prior atherosclerotic cardiovascular disease (ASCVD) who had the data necessary to calculate the AHA-PREVENT 10-year risk of developing ASCVD in the event period (2007-2016). Patients with prior ASCVD events, death prior to 2007, or age 79 years or older in 2007 were subsequently excluded. The final study population of 95\u202f326 patients was split into 3 nonoverlapping subsets for training, testing, and validation. The AHA-PREVENT model was adapted to this local population using the open-source ML model (MLM) Extreme Gradient Boosting model (XGBoost) with minimal predictor variables, including age, sex, and AHA-PREVENT. The MLM was monotonically constrained to preserve known associations between risk factors and ASCVD risk. Along with sex, race and ethnicity data from the electronic health record were collected to validate the performance of ASCVD risk prediction in subgroups. Data were analyzed from August 2021 to February 2024.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Consistent with the AHA-PREVENT model, ASCVD events were defined as the first occurrence of either nonfatal myocardial infarction, coronary artery disease, ischemic stroke, or cardiovascular death. Cardiovascular death was coded via government registries. Discrimination, calibration, and risk reclassification were assessed using the Harrell C index, a modified Hosmer-Lemeshow goodness-of-fit test and calibration curves, and reclassification tables, respectively.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In the test set of 38\u202f137 patients (mean [SD] age, 64.8 [6.9] years, 22\u202f708 [59.5]% women and 15\u202f429 [40.5%] men; 935 [2.5%] Asian, 2153 [5.6%] Black, 1414 [3.7%] Hispanic, 31\u202f400 [82.3%] White, and 2235 [5.9%] other, including American Indian, multiple races, unspecified, and unrecorded, consolidated owing to small numbers), MLM-PREVENT had improved calibration (modified Hosmer-Lemeshow\n P<\/jats:italic>\n \u2009&amp;gt;\u2009.05) compared to the AHA-PREVENT model across risk categories in the overall cohort (\u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009=\u20092.2; P\u2009=\u2009.53 vs \u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009&amp;gt;\u200916.3;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and sex subgroups (men: \u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009=\u20092.1;\n P<\/jats:italic>\n \u2009=\u2009.55 vs \u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009&amp;gt;\u200916.3;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; women: \u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009=\u20096.5;\n P<\/jats:italic>\n \u2009=\u2009.09 vs. \u03c7\n 2<\/jats:sup>\n 3<\/jats:sub>\n \u2009&amp;gt;\u200916.3;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), while also surpassing a traditional recalibration approach. MLM-PREVENT maintained or improved AHA-PREVENT\u2019s calibration in Asian, Black, and White individuals. Both MLM-PREVENT and AHA-PREVENT performed equally well in discriminating risk (approximate \u0394C index, \u00b10.01). Using a clinically significant 7.5% risk threshold, MLM-PREVENT reclassified a total of 11.5% of patients. We visualize the recalibration through MLM-PREVENT ASCVD risk charts that highlight preserved risk associations of the original AHA-PREVENT model.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The interpretable ML approach presented in this article enhanced the accuracy of the AHA-PREVENT model when applied to a local population while still preserving the risk associations found by the original model. This method has the potential to recalibrate other established risk tools and is implementable in electronic health record systems for improved cardiovascular risk assessment.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamacardio.2024.2912","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T11:01:07Z","timestamp":1726657267000},"page":"1018","source":"Crossref","is-referenced-by-count":32,"title":["Tailoring Risk Prediction Models to Local Populations"],"prefix":"10.1001","volume":"9","author":[{"given":"Aniket N.","family":"Zinzuwadia","sequence":"first","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mineeva","sequence":"additional","affiliation":[{"name":"ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zareen","family":"Farukhi","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"},{"name":"Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Giulianini","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cade","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Karlson","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Paynter","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Mora","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Demler","sequence":"additional","affiliation":[{"name":"Brigham & Women\u2019s Hospital, Boston, Massachusetts"},{"name":"ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"25","key":"hoi240052r1","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology.","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation"},{"issue":"34","key":"hoi240052r2","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"hoi240052r3","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.","volume":"42","author":"SCORE2 Working Group","year":"2021","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi240052r4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular M\u00fcnster (PROCAM) study.","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"hoi240052r5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update.","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9","key":"hoi240052r6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018410","article-title":"Performance of the pooled cohort equations in Hispanic individuals across the United States: insights from the Multi-Ethnic Study of Atherosclerosis and the Dallas Heart Study.","volume":"10","author":"Flores Rosario","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"hoi240052r7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk.","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"issue":"7","key":"hoi240052r8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/eurheartj\/ehy653","article-title":"Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.","volume":"40","author":"Pennells","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi240052r9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12916-019-1340-7","article-title":"Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.","volume":"17","author":"Damen","year":"2019","journal-title":"BMC Med"},{"issue":"3","key":"hoi240052r10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jamia\/ocaa283","article-title":"Addressing bias in prediction models by improving subpopulation calibration.","volume":"28","author":"Barda","year":"2021","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"hoi240052r11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12916-019-1368-8","article-title":"The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.","volume":"17","author":"Pate","year":"2019","journal-title":"BMC Med"},{"issue":"7","key":"hoi240052r12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.healun.2022.03.019","article-title":"Temporal shift and predictive performance of machine learning for heart transplant outcomes.","volume":"41","author":"Miller","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"hoi240052r13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jamacardio.2022.1883","article-title":"Time to revisit using 10-year risk to guide statin therapy.","volume":"7","author":"Navar","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hoi240052r14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41746-021-00426-3","article-title":"Machine learning for patient risk stratification: standing on, or looking over, the shoulders of clinicians?","volume":"4","author":"Beaulieu-Jones","year":"2021","journal-title":"NPJ Digit Med"},{"issue":"1","key":"hoi240052r15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13104-019-4293-1","article-title":"External validation of pooled cohort equations using systolic blood pressure intervention trial data.","volume":"12","author":"Kuragaichi","year":"2019","journal-title":"BMC Res Notes"},{"issue":"19","key":"hoi240052r16","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2020.19392","article-title":"Testing clinical prediction models.","volume":"324","author":"Goldstein","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"hoi240052r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000023","article-title":"Generalizability challenges of mortality risk prediction models: a retrospective analysis on a multi-center database.","volume":"1","author":"Singh","year":"2022","journal-title":"PLOS Digit Health"},{"issue":"6","key":"hoi240052r18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT Equations.","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"hoi240052r19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics.","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"1","key":"hoi240052r20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12911-019-0918-5","article-title":"A data-driven approach to predicting diabetes and cardiovascular disease with machine learning.","volume":"19","author":"Dinh","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"hoi240052r23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41591-020-0789-4","article-title":"Early prediction of circulatory failure in the intensive care unit using machine learning.","volume":"26","author":"Hyland","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"hoi240052r24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007363","article-title":"Toward dynamic risk prediction of outcomes after coronary artery bypass graft: improving risk prediction with intraoperative events using gradient boosting.","volume":"14","author":"Mori","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"hoi240052r25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41598-018-36745-x","article-title":"Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction.","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci Rep"},{"issue":"24","key":"hoi240052r26","doi-asserted-by":"publisher","first-page":"13193","DOI":"10.3390\/ijerph182413193","article-title":"Constructing epidemiologic cohorts from electronic health record data.","volume":"18","author":"Williams","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"hoi240052r27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cpt.861","article-title":"Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data.","volume":"103","author":"Lin","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"hoi240052r28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/CLEP.S232540","article-title":"External validation of an algorithm to identify patients with high data-completeness in electronic health records for comparative effectiveness research.","volume":"12","author":"Lin","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"1","key":"hoi240052r29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5334\/egems.243","article-title":"Illustrating informed presence bias in electronic health records data: how patient interactions with a health system can impact inference.","volume":"5","author":"Phelan","year":"2017","journal-title":"EGEMS (Wash DC)"},{"issue":"5","key":"hoi240052r30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/jamia\/ocac019","article-title":"Observability and its impact on differential bias for clinical prediction models.","volume":"29","author":"Yan","year":"2022","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"hoi240052r31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jamia\/ocx111","article-title":"Enabling phenotypic big data with PheNorm.","volume":"25","author":"Yu","year":"2018","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"hoi240052r32","first-page":"1","article-title":"Trends in cancer and heart disease death rates among adults aged 45-64: United States, 1999-2017.","volume":"68","author":"Curtin","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"19","key":"hoi240052r33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"18","key":"hoi240052r34","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests.","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"issue":"10","key":"hoi240052r35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"issue":"10","key":"hoi240052r36","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/sim.6428","article-title":"Tests of calibration and goodness-of-fit in the survival setting.","volume":"34","author":"Demler","year":"2015","journal-title":"Stat Med"},{"issue":"11","key":"hoi240052r38","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"hoi240052r39","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations.","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"29","key":"hoi240052r40","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"hoi240052r43","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1177\/0962280213497434","article-title":"Assessing calibration of prognostic risk scores.","volume":"25","author":"Crowson","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"16","key":"hoi240052r44","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jacc.2021.08.018","article-title":"Proteomics-enabled deep learning machine algorithms can enhance prediction of mortality.","volume":"78","author":"Unterhuber","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi240052r45","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/cvr\/cvz321","article-title":"Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study.","volume":"116","author":"Commandeur","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"2","key":"hoi240052r46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cjca.2021.09.004","article-title":"Opening the black box: the promise and limitations of explainable machine learning in cardiology.","volume":"38","author":"Petch","year":"2022","journal-title":"Can J Cardiol"},{"key":"hoi240052r47","doi-asserted-by":"publisher","DOI":"10.1177\/11795468221133611","article-title":"XGBoost, a novel explainable ai technique, in the prediction of myocardial infarction: a UK Biobank cohort study.","volume":"16","author":"Moore","year":"2022","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"hoi240052r48","doi-asserted-by":"publisher","first-page":"21905","DOI":"10.1038\/s41598-022-25933-5","article-title":"Explainable machine learning framework for predicting long-term cardiovascular disease risk among adolescents.","volume":"12","author":"Salah","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"hoi240052r49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/eurheartj\/ehad748","article-title":"Adapting cardiovascular risk prediction models to different populations: the need for recalibration.","volume":"45","author":"Pennells","year":"2023","journal-title":"Eur Heart J"},{"issue":"7","key":"hoi240052r50","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/eurheartj\/ehy726","article-title":"Is \u2018re-calibration\u2019 of standard cardiovascular disease (CVD) risk algorithms the panacea to improved CVD risk prediction and prevention?","volume":"40","author":"Laukkanen","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"hoi240052r51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/jamainternmed.2021.2626","article-title":"External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients.","volume":"181","author":"Wong","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"8","key":"hoi240052r52","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamainternmed.2021.3333","article-title":"The epic sepsis model falls short-the importance of external validation.","volume":"181","author":"Habib","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"6","key":"hoi240052r53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamainternmed.2022.7182","article-title":"Factors associated with variability in the performance of a proprietary sepsis prediction model across 9 networked hospitals in the US.","volume":"183","author":"Lyons","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"5","key":"hoi240052r54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead.","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"2","key":"hoi240052r55","doi-asserted-by":"publisher","DOI":"10.1162\/99608f92.5a8a3a3d","article-title":"Why are we using black box models in AI when we don\u2019t need to? a lesson from an explainable AI competition.","volume":"1","author":"Rudin","year":"2019","journal-title":"Harv Data Sci Rev"},{"issue":"48","key":"hoi240052r56","doi-asserted-by":"publisher","first-page":"30088","DOI":"10.1073\/pnas.1907377117","article-title":"On instabilities of deep learning in image reconstruction and the potential costs of AI.","volume":"117","author":"Antun","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"hoi240052r57","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association.","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"hoi240052r58","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight\u2014reconsidering the use of race correction in clinical algorithms.","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"hoi240052r59","first-page":"135","article-title":"Removal of race from estimates of kidney function: first, do no harm.","volume":"325","author":"Norris","year":"2021","journal-title":"JAMA"},{"issue":"6464","key":"hoi240052r60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations.","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"issue":"2","key":"hoi240052r61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/jama.2019.5774","article-title":"Reconsidering the consequences of using race to estimate kidney function.","volume":"322","author":"Eneanya","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"hoi240052r62","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2589-7500(21)00236-3","article-title":"Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study.","volume":"4","author":"Vasan","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"1","key":"hoi240052r63","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/S2589-7500(21)00258-2","article-title":"Revising the atherosclerotic cardiovascular disease calculator without race.","volume":"4","author":"Vyas","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"11","key":"hoi240052r64","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/aje\/kww112","article-title":"Controlling for informed presence bias due to the number of health encounters in an electronic health record.","volume":"184","author":"Goldstein","year":"2016","journal-title":"Am J Epidemiol"},{"key":"hoi240052r21","author":"Athanasiou","year":"2020"},{"key":"hoi240052r22","author":"Rajliwall","year":"2018"},{"key":"hoi240052r37","first-page":"1","volume-title":"Handbook of Statistics","author":"D\u2019Agostino","year":"2003"},{"key":"hoi240052r41","author":"Chen","year":"2016"},{"key":"hoi240052r42","unstructured":"Lin, I. IyarLin\/survXgboost. 2024. https:\/\/github.com\/IyarLin\/survXgboost"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2823894\/jamacardiology_zinzuwadia_2024_oi_240052_1730392573.6673.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:41:21Z","timestamp":1731498081000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2823894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.2912","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}